Background Psoriasis is an immune‐mediated disease with either skin or joints
manifestations, or both, and it has a major impact on quality of life. Although there is …

Psoriasis is a common inflammatory skin disease involving interactions between
keratinocytes and immune cells that significantly affects the quality of life. It is characterized …

Background Network meta-analysis (NMA) has been widely used in the field of medicine
and health, but the research topics and development trends are still unclear. This study …

Background: Psoriasis is a multifactorial immune-mediated inflammatory disease, with a
chronic relapsing-remitting course, which affects 2-3% of the worldwide population …

Introduction: The treatment of psoriasis with conventional topical therapies and disease-
modifying anti-rheumatic drugs (DMARDs) is often linked to unsatisfactory outcomes and the …

Erythrodermic psoriasis (EP) is an extreme and often refractory variant of psoriasis with high
morbidity and increased mortality, and is frequently classified as a dermatological …

Type I interferons (IFN-I) are key immune messenger molecules that play an important role
in viral defense. They act as a bridge between microbe sensing, immune function …

Introduction: Psoriasis is a common, immune-mediated skin disease often associated with
significant physical and psychosocial impairment. Antipsoriatic biologic agents offer patients …

Introduction Certolizumab pegol (CZP) is an anti-tumor necrosis factor alpha (TNFα)
approved for the treatment of moderate to severe plaque psoriasis (PSO). However, data on …

The new era of immune and reconstitution therapy of autoimmune disorders is ongoing.
However, endocrine autoimmune diseases comprise a group of elaborating pathologies …